Treatment of Staphylococcus aureus Pneumonia in Healthy Adults with Community-Acquired Pneumonia (Outpatient)
This protocol covers the antibiotic management of community-acquired pneumonia in adults treated entirely in the outpatient setting who have no significant comorbidities and no risk factors for antibiotic-resistant pathogens.
Clinical Scenario
The patient is an adult with community-acquired pneumonia managed in the outpatient setting, without chronic heart, lung, liver, or renal disease, diabetes mellitus, alcoholism, malignancy, or asplenia. There is no prior respiratory isolation of MRSA and no recent hospitalization with parenteral antibiotics in the last 90 days.
Treatment Approach
For this low-risk outpatient population, guidelines support oral antibiotic therapy from a small set of recommended options. Therapy is continued until the patient achieves clinical stability and for a defined minimum total duration. The complete regimen, the list of supported agents, and duration criteria are detailed in the structured protocol.
Clinical Goals
Treatment aims for clinical stability: resolution of vital sign abnormalities (heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature), ability to eat, and normal mentation. Most patients achieve clinical stability within the first 48 to 72 hours.
References
DOI: 10.1164/rccm.201908-1581ST
- For healthy outpatient adults without comorbidities listed below or risk factors for antibiotic resistant pathogens, we recommend (Table 3):
- amoxicillin 1 g three times daily (strong recommendation, moderate quality of evidence), or
- doxycycline 100 mg twice daily (conditional recommendation, low quality of evidence), or
- a macrolide (azithromycin 500 mg on first day then 250 mg daily or clarithromycin 500 mg twice daily or clarithromycin extended release 1,000 mg daily) only in areas with pneumococcal resistance to macrolides <25% (conditional recommendation, moderate quality of evidence).
- antibiotic therapy should be continued until the patient achieves stability and for no less than a total of 5 days (strong recommendation, moderate quality of evidence).
- We recommend that the duration of antibiotic therapy should be guided by a validated measure of clinical stability (resolution of vital sign abnormalities [heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature], ability to eat, and normal mentation), and antibiotic therapy should be continued until the patient achieves stability and for no less than a total of 5 days (strong recommendation, moderate quality of evidence).
- As most patients will achieve clinical stability within the first 48 to 72 hours, a total duration of therapy of 5 days will be appropriate for most patients.
View source ↗